Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Dysphagia
Erschienen in: Dysphagia 5/2021

02.01.2021 | Review

The Effect of Deep Brain Stimulation on Swallowing Function in Parkinson’s Disease: A Narrative Review

verfasst von: Min Cheol Chang, Jin-Sung Park, Byung Joo Lee, Donghwi Park

Erschienen in: Dysphagia | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Unlike appendicular motor symptoms, such as bradykinesia and rigidity, in Parkinson’s disease (PD), which have already been reported to respond well to deep brain stimulation (DBS), there is limited literature on the effects of DBS on swallowing function in patients with PD. The field lacks consensus as there are conflicting reports among existing studies regarding whether swallowing function improves or declines following DBS implantation. This narrative review aims to summarize and analyze the studies published on the effect of DBS on swallowing function in patients with PD. We collated studies published up to February 2020 using a comprehensive electronic database search of PubMed, SCOPUS, EMBASE, and the Cochrane Library. Two reviewers independently assessed the studies using strict inclusion and exclusion criteria. The primary literature search yielded 529 relevant papers. After reading their titles and abstracts and assessing their eligibility based on the full-text, we finally included and reviewed 14 publications. Nine of these studies reported positive effects of DBS on swallowing function and four studies showed no significant positive results. The remaining study showed decreased swallowing function after unilateral subthalamic nucleus-DBS surgery. In conclusion, we found that DBS has the potential to improve swallowing function in patients with PD. However, high-quality evidence is lacking. To clearly elucidate the effect of DBS on swallowing function in patients with PD, high-quality randomized controlled trials should be conducted in the future.
Literatur
1.
DeMaagd G, Philip A. Parkinson’s disease and its management: Part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. P & T Peer Rev J Formul Manag. 2015;40:504–32.
2.
Yu KJ, Lee BJ, Han J, Park D. Usefulness of F-18 FP-CIT PET to predict dopamine-responsive hand tremor in patients other than Parkinson’s disease: two case reports. Medicine (Baltim). 2018;97:e10983.CrossRef
3.
Park D. Pramipexole-induced limb dystonia and its associated complex regional pain syndrome in idiopathic Parkinson’s disease: a case report. Medicine (Baltim). 2017a;96:e7530.CrossRef
4.
Alexander GE. Biology of Parkinson’s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues Clin Neurosci. 2004;6:259–80.PubMedPubMedCentralCrossRef
5.
Berganzo K, Tijero B, Gonzalez-Eizaguirre A, Somme J, Lezcano E, Gabilondo I, Fernandez M, Zarranz JJ, Gomez-Esteban JC. Motor and non-motor symptoms of Parkinson’s disease and their impact on quality of life and on different clinical subgroups. Neurologia. 2016;31:585–91.PubMedCrossRef
6.
7.
8.
Kalf JG, de Swart BJ, Bloem BR, Munneke M. Prevalence of oropharyngeal dysphagia in Parkinson’s disease: a meta-analysis. Parkinsonism Relat Disord. 2012;18:311–5.PubMedCrossRef
9.
Ortega O, Martin A, Clave P. Diagnosis and management of oropharyngeal dysphagia among older persons, state of the art. J Am Med Dir Assoc. 2017;18:576–82.PubMedCrossRef
10.
11.
Yu KJ, Park D. Clinical characteristics of dysphagic stroke patients with salivary aspiration: a STROBE-compliant retrospective study. Medicine (Baltim). 2019;98:e14977.CrossRef
12.
13.
Mu L, Sobotka S, Chen J, Su H, Sanders I, Adler CH, Shill HA, Caviness JN, Samanta JE, Beach TG, Arizona Parkinson’s Disease Consortium. Altered pharyngeal muscles in Parkinson disease. J Neuropathol Exp Neurol. 2012;71:520–30.PubMedCrossRef
14.
Takizawa C, Gemmell E, Kenworthy J, Speyer R. A systematic review of the prevalence of oropharyngeal dysphagia in stroke, Parkinson’s disease, Alzheimer’s disease, head injury, and pneumonia. Dysphagia. 2016;31:434–41.PubMedCrossRef
15.
Baijens LW, Speyer R, Passos VL, Pilz W, Roodenburg N, Clave P. Swallowing in Parkinson patients versus healthy controls: reliability of measurements in videofluoroscopy. Gastroenterol Res Pract. 2011;2011:380682.PubMedPubMedCentralCrossRef
16.
Manor Y, Mootanah R, Freud D, Giladi N, Cohen JT. Video-assisted swallowing therapy for patients with Parkinson’s disease. Parkinsonism Relat Disord. 2013;19:207–11.PubMedCrossRef
17.
Pflug C, Nienstedt JC, Gulberti A, Muller F, Vettorazzi E, Koseki JC, Niessen A, Flugel T, Hidding U, Buhmann C, Weiss D, Gerloff C, Hamel W, Moll CKE, Potter-Nerger M. Impact of simultaneous subthalamic and nigral stimulation on dysphagia in Parkinson’s disease. Ann Clin Transl Neurol. 2020;7:628–38.PubMedPubMedCentralCrossRef
18.
Troche MS, Brandimore AE, Foote KD, Okun MS. Swallowing and deep brain stimulation in Parkinson’s disease: a systematic review. Parkinsonism Relat Disord. 2013;19:783–8.PubMedPubMedCentralCrossRef
19.
Heijnen BJ, Speyer R, Baijens LW, Bogaardt HC. Neuromuscular electrical stimulation versus traditional therapy in patients with Parkinson’s disease and oropharyngeal dysphagia: effects on quality of life. Dysphagia. 2012;27:336–45.PubMedCrossRef
20.
Argolo N, Sampaio M, Pinho P, Melo A, Nobrega AC. Do swallowing exercises improve swallowing dynamic and quality of life in Parkinson’s disease? NeuroRehabilitation. 2013;32:949–55.PubMedCrossRef
21.
Born LJ, Harned RH, Rikkers LF, Pfeiffer RF, Quigley EM. Cricopharyngeal dysfunction in Parkinson’s disease: role in dysphagia and response to myotomy. Mov Disord Off J Mov Disord Soc. 1996;11:53–8.CrossRef
22.
Warnecke T, Suttrup I, Schroder JB, Osada N, Oelenberg S, Hamacher C, Suntrup S, Dziewas R. Levodopa responsiveness of dysphagia in advanced Parkinson’s disease and reliability testing of the FEES-Levodopa-test. Parkinsonism Relat Disord. 2016;28:100–6.PubMedCrossRef
23.
Park D. Correspondence: the pathophysiology of pramipexole-associated dystonia in patients with Parkinson’s disease. Parkinsonism Relat Disord. 2017b;38:106–7.PubMedCrossRef
24.
Troche MS, Sapienza CM, Rosenbek JC. Effects of bolus consistency on timing and safety of swallow in patients with Parkinson’s disease. Dysphagia. 2008;23:26–32.PubMedCrossRef
25.
Ayres A, Jotz GP, Rieder CR, Olchik MR. Benefit from the chin-down maneuver in the swallowing performance and self-perception of Parkinson’s disease patients. Parkinson’s Dis. 2017;2017:7460343.
26.
Hartmann CJ, Fliegen S, Groiss SJ, Wojtecki L, Schnitzler A. An update on best practice of deep brain stimulation in Parkinson’s disease. Ther Adv Neurol Disord. 2019;12:1756286419838096.PubMedPubMedCentral
27.
Siwek J, Gourlay ML, Slawson DC, Shaughnessy AF. How to write an evidence-based clinical review article. Am Fam Physician. 2002;65:251–8.PubMed
28.
Martinez-Martin P, Skorvanek M, Rojo-Abuin JM, Gregova Z, Stebbins GT, Goetz CG. Members of the QSG: Validation study of the Hoehn and Yahr scale included in the MDS-UPDRS. Mov Disord Off J Mov Disord Soc. 2018;33:651–2.CrossRef
29.
Wajsbort J. The “off-on” phenomenon during treatment of Parkinson’s disease with levodopa (author’s transl). J Neurol. 1977;215:59–66.PubMedCrossRef
30.
Zibetti M, Torre E, Cinquepalmi A, Rosso M, Ducati A, Bergamasco B, Lanotte M, Lopiano L. Motor and nonmotor symptom follow-up in Parkinsonian patients after deep brain stimulation of the subthalamic nucleus. Eur Neurol. 2007;58:218–23.PubMedCrossRef
31.
Ciucci MR, Barkmeier-Kraemer JM, Sherman SJ. Subthalamic nucleus deep brain stimulation improves deglutition in Parkinson’s disease. Mov Disord Off J Mov Disord Soc. 2008;23:676–83.CrossRef
32.
Kitashima A, Umemoto G, Tsuboi Y, Higuchi MA, Baba Y, Kikuta T. Effects of subthalamic nucleus deep brain stimulation on the swallowing function of patients with Parkinson’s disease. Parkinsonism Relat Disord. 2013;19:480–2.PubMedCrossRef
33.
Kulneff L, Sundstedt S, Olofsson K, van Doorn J, Linder J, Nordh E, Blomstedt P. Deep brain stimulation—effects on swallowing function in Parkinson’s disease. Acta Neurol Scand. 2013;127:329–36.PubMedCrossRef
34.
Lengerer S, Kipping J, Rommel N, Weiss D, Breit S, Gasser T, Plewnia C, Kruger R, Wachter T. Deep-brain-stimulation does not impair deglutition in Parkinson’s disease. Parkinsonism Relat Disord. 2012;18:847–53.PubMedCrossRef
35.
Silbergleit AK, LeWitt P, Junn F, Schultz LR, Collins D, Beardsley T, Hubert M, Trosch R, Schwalb JM. Comparison of dysphagia before and after deep brain stimulation in Parkinson’s disease. Mov Disord Off J Mov Disord Soc. 2012;27:1763–8.CrossRef
36.
Wolz M, Hauschild J, Koy J, Fauser M, Klingelhofer L, Schackert G, Reichmann H, Storch A. Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson’s disease. Parkinsonism Relat Disord. 2012;18:994–7.PubMedCrossRef
37.
Xie T, Vigil J, MacCracken E, Gasparaitis A, Young J, Kang W, Bernard J, Warnke P, Kang UJ. Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD. Neurology. 2015;84:415–20.PubMedPubMedCentralCrossRef
38.
Olchik MR, Ghisi M, Ayres A, Schuh AFS, Oppitz PP, Rieder CRM. The impact of deep brain stimulation on the quality of life and swallowing in individuals with Parkinson’s disease. Int Arch Otorhinolaryngol. 2018;22:125–9.PubMedCrossRef
39.
Xie T, Bloom L, Padmanaban M, Bertacchi B, Kang W, MacCracken E, Dachman A, Vigil J, Satzer D, Zadikoff C, Markopoulou K, Warnke P, Kang UJ. Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PD. J Neurol Neurosurg Psychiatry. 2018;89:989–94.PubMedCrossRef
40.
Troche MS, Brandimore AE, Foote KD, Morishita T, Chen D, Hegland KW, Okun MS. Swallowing outcomes following unilateral STN vs GPi surgery: a retrospective analysis. Dysphagia. 2014;29:425–31.PubMedPubMedCentralCrossRef
41.
Sundstedt S, Olofsson K, van Doorn J, Linder J, Nordh E, Blomstedt P. Swallowing function in Parkinson’s patients following Zona Incerta deep brain stimulation. Acta Neurol Scand. 2012;126:350–6.PubMedCrossRef
42.
Sundstedt S, Holmen L, Rova E, Linder J, Nordh E, Olofsson K. Swallowing safety in Parkinson’s disease after zona incerta deep brain stimulation. Brain Behav. 2017;7:e00709.PubMedPubMedCentralCrossRef
43.
Sundstedt S, Nordh E, Linder J, Hedstrom J, Finizia C, Olofsson K. Swallowing quality of life after zona incerta deep brain stimulation. Ann Otol Rhinol Laryngol. 2017;126:110–6.PubMedCrossRef
44.
Lester DB, Rogers TD, Blaha CD. Neuronal pathways involved in deep brain stimulation of the subthalamic nucleus for treatment of Parkinson’s disease. Annu Int Conf IEEE Eng Med Biol Soc. 2009;2009:3302–5.PubMed
45.
Ossowska K. Zona incerta as a therapeutic target in Parkinson’s disease. J Neurol. 2020;267:591–606.PubMedCrossRef
46.
Dostrovsky JO, Levy R, Wu JP, Hutchison WD, Tasker RR, Lozano AM. Microstimulation-induced inhibition of neuronal firing in human globus pallidus. J Neurophysiol. 2000;84:570–4.PubMedCrossRef
47.
Hariz MI, Rehncrona S, Quinn NP, Speelman JD, Wensing C, Multicentre Advanced Parkinson’s Disease Deep Brain Stimulation Group. Multicenter study on deep brain stimulation in Parkinson’s disease: an independent assessment of reported adverse events at 4 years. Mov Disord Off J Mov Disord Soc. 2008;23:416–21.CrossRef
48.
St George RJ, Carlson-Kuhta P, Burchiel KJ, Hogarth P, Frank N, Horak FB. The effects of subthalamic and pallidal deep brain stimulation on postural responses in patients with Parkinson disease. J Neurosurg. 2012;116:1347–56.PubMedPubMedCentralCrossRef
49.
Bastian AJ, Kelly VE, Revilla FJ, Perlmutter JS, Mink JW. Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson’s disease. Mov Disord Off J Mov Disord Soc. 2003;18:1000–7.CrossRef
50.
Chung SJ, Jeon SR, Kim SR, Sung YH, Lee MC. Bilateral effects of unilateral subthalamic nucleus deep brain stimulation in advanced Parkinson’s disease. Eur Neurol. 2006;56:127–32.PubMedCrossRef
51.
Germano IM, Gracies JM, Weisz DJ, Tse W, Koller WC, Olanow CW. Unilateral stimulation of the subthalamic nucleus in Parkinson disease: a double-blind 12-month evaluation study. J Neurosurg. 2004;101:36–42.PubMedCrossRef
52.
Kumar R, Lozano AM, Sime E, Halket E, Lang AE. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation. Neurology. 1999;53:561–6.PubMedCrossRef
53.
Zahodne LB, Okun MS, Foote KD, Fernandez HH, Rodriguez RL, Wu SS, Kirsch-Darrow L. Jacobson CEt, Rosado C, Bowers D: Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus. J Neurol. 2009;256:1321–9.PubMedPubMedCentralCrossRef
54.
Taba HA, Wu SS, Foote KD, Hass CJ, Fernandez HH, Malaty IA, Rodriguez RL, Dai Y, Zeilman PR, Jacobson CE, Okun MS. A closer look at unilateral versus bilateral deep brain stimulation: results of the National Institutes of Health COMPARE cohort. J Neurosurg. 2010;113:1224–9.PubMedCrossRef
55.
Samii A, Kelly VE, Slimp JC, Shumway-Cook A, Goodkin R. Staged unilateral versus bilateral subthalamic nucleus stimulator implantation in Parkinson disease. Mov Disord Off J Mov Disord Soc. 2007;22:1476–81.CrossRef
Metadaten
Titel
The Effect of Deep Brain Stimulation on Swallowing Function in Parkinson’s Disease: A Narrative Review
verfasst von
Min Cheol Chang
Jin-Sung Park
Byung Joo Lee
Donghwi Park
Publikationsdatum
02.01.2021
Verlag
Springer US
Erschienen in
Dysphagia / Ausgabe 5/2021
Print ISSN: 0179-051X
Elektronische ISSN: 1432-0460
DOI
https://doi.org/10.1007/s00455-020-10214-y

Weitere Artikel der Ausgabe 5/2021

Dysphagia 5/2021 Zur Ausgabe

Original Article

Sensitivity and Specificity of Bedside Screening Tests for Detection of Aspiration in Patients Admitted to a Public Rehabilitation Hospital

Original Article

Depression, Anxiety, and Stress Relative to Swallowing Impairment in Persons with Multiple Sclerosis

Original Article

Is Dysphagia Under Diagnosed or is Normal Swallowing More Variable than We Think? Reported Swallowing Problems in People Aged 18–65 Years

Original Article

Abnormalities of Aspiration and Swallowing Function in Survivors of Acute Respiratory Failure

Original Article

Clinical Association Between Nasopharyngeal Reflux and Aspiration

Original Article

Pharyngeal Deposits Comprising Salivary Mucin in Tube-fed Elderly Patients: MUC2 and MUC7 Immunoreactivity

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise